The production and distribution of drugs for the US market from Ranabaxy's Toansa facility in Punjab has been prohibited by the US drug regulator, causing another setback. The US Food and Drug Administration (FDA) Thursday notified Ranbaxy Laboratories Ltd that its facility in Toansa had been added to the consent decree of permanent injunction entered against Ranbaxy in January 2012. The decree contains, among other things, provisions to ensure compliance ...
Read More
You have just read an article categorized health
titled More Products from Ranbaxy Get Banned by the US FDA.
Written by:
editor -
Saturday, January 25, 2014
There are currently no comments for "More Products from Ranbaxy Get Banned by the US FDA"
Post a Comment